Literature DB >> 14977950

Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Jennifer A Shumilla1, Vashti Lacaille, Tara M C Hornell, Jennifer Huang, Supraja Narasimhan, David A Relman, Elizabeth D Mellins.   

Abstract

Bordetella pertussis is the causative agent of whooping cough, a potentially lethal respiratory disease in children. In immunocompetent individuals, B. pertussis infection elicits an effective adaptive immune response driven by activated CD4(+) T cells. However, live B. pertussis persists in the host for 3 to 4 weeks prior to clearance. Thus, B. pertussis appears to have evolved short-term mechanisms for immune system evasion. We investigated the effects of B. pertussis wild-type strain BP338 on antigen presentation in primary human monocytes. BP338 infection reduced cell surface expression of HLA-DR and CD86 but not that of major histocompatibility complex class I proteins. This change in cell surface HLA-DR expression reflected intracellular redistribution of HLA-DR. The proportion of peptide-loaded molecules was unchanged in infected cells, suggesting that intracellular retention occurred after peptide loading. Although B. pertussis infection of monocytes induced rapid and robust expression of interleukin-10 (IL-10), HLA-DR redistribution did not appear to be explained by increased IL-10 levels. BP338-infected monocytes exhibited reduced synthesis of HLA-DR dimers. Interestingly, those HLA-DR proteins that were generated appeared to be longer-lived than HLA-DR in uninfected monocytes. BP338 infection also prevented gamma interferon (IFN-gamma) induction of HLA-DR protein synthesis. Using mutant strains of B. pertussis, we found that reduction in HLA-DR surface expression was due in part to the presence of pertussis toxin whereas the inhibition of IFN-gamma induction of HLA-DR could not be linked to any of the virulence factors tested. These data demonstrate that B. pertussis utilizes several mechanisms to modulate HLA-DR expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977950      PMCID: PMC356037          DOI: 10.1128/IAI.72.3.1450-1462.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

Review 1.  Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Authors:  J R Kerr; R C Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

2.  Study of monomorphic determinants on DR molecules of HLA class II antigens.

Authors:  K Poláková; M Karpatová
Journal:  Neoplasma       Date:  1990       Impact factor: 2.575

3.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes.

Authors:  E Mellins; L Smith; B Arp; T Cotner; E Celis; D Pious
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

4.  Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence.

Authors:  D A Relman; M Domenighini; E Tuomanen; R Rappuoli; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.

Authors:  D Relman; E Tuomanen; S Falkow; D T Golenbock; K Saukkonen; S D Wright
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 6.  Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes.

Authors:  S V Kotenko; S Pestka
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

7.  Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

Authors:  M Mouallem; Z Farfel; E Hanski
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

8.  Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

Authors:  M A Blanar; E C Boettger; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  13 in total

1.  Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.

Authors:  Giorgio Fedele; Paola Stefanelli; Fabiana Spensieri; Cecilia Fazio; Paola Mastrantonio; Clara M Ausiello
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Influence of pertussis toxin on CD1a isoform expression in human dendritic cells.

Authors:  Angelo Martino; Elisabetta Volpe; Giovanni Auricchio; Vittorio Colizzi; Patrizia Morena Baldini
Journal:  J Clin Immunol       Date:  2006-04-06       Impact factor: 8.317

4.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

5.  Intracellular trafficking of Bordetella pertussis in human macrophages.

Authors:  Yanina A Lamberti; Jimena Alvarez Hayes; Maria L Perez Vidakovics; Eric T Harvill; Maria Eugenia Rodriguez
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

6.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

Review 7.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

8.  Bordetella Pertussis Toxin does not induce the release of pro-inflammatory cytokines in human whole blood.

Authors:  Christina Bache; Ingo Spreitzer; Bjoern Becker; Bettina Loeschner; Ute Rosskopf; Kay-Martin Hanschmann; Michael Schwanig; Christian K Schneider; Bernhard Lieb; Thomas Montag
Journal:  Med Microbiol Immunol       Date:  2012-04-15       Impact factor: 3.402

9.  Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

Authors:  Victor I Ayala; John R Teijaro; Donna L Farber; Susan G Dorsey; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

10.  Genome-wide association study identifies SNPs in the MHC class II loci that are associated with self-reported history of whooping cough.

Authors:  George McMahon; Susan M Ring; George Davey-Smith; Nicholas J Timpson
Journal:  Hum Mol Genet       Date:  2015-07-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.